Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Ribavirin
Page 1 of 2 ( 52 items )
<<
1
2
>>
1
Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment
2/24/2023 1:35:50 PM |
Browse: 628 |
Download: 1402
2
Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C
12/2/2022 12:50:19 PM |
Browse: 667 |
Download: 2106
3
Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages
6/24/2021 7:26:32 AM |
Browse: 709 |
Download: 2086
4
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over
9/21/2020 4:02:08 PM |
Browse: 928 |
Download: 2710
5
Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
5/6/2019 10:43:10 AM |
Browse: 1360 |
Download: 2724
6
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
4/4/2018 1:15:45 PM |
Browse: 1484 |
Download: 2986
7
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
12/5/2017 1:55:00 AM |
Browse: 1464 |
Download: 2724
8
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
5/17/2017 6:29:40 AM |
Browse: 1723 |
Download: 3147
9
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection
2/6/2017 9:08:00 AM |
Browse: 1365 |
Download: 2972
10
Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin
1/22/2017 8:28:00 AM |
Browse: 1825 |
Download: 3012
11
Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
11/18/2016 3:13:00 PM |
Browse: 1365 |
Download: 3042
12
Retrospective study of the associations between hepatitis C virus infection and metabolic factors
10/25/2016 8:46:00 AM |
Browse: 1949 |
Download: 3349
13
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
10/12/2016 2:18:00 PM |
Browse: 1634 |
Download: 2108
14
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience
8/3/2016 8:11:00 AM |
Browse: 1974 |
Download: 3367
15
Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus
3/2/2016 1:35:00 PM |
Browse: 2066 |
Download: 3925
16
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma
2/25/2016 7:04:00 PM |
Browse: 1439 |
Download: 2783
17
Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
2/22/2016 3:38:00 PM |
Browse: 1663 |
Download: 3332
18
Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-/ribavirin therapy
1/23/2016 5:08:00 PM |
Browse: 1708 |
Download: 2459
19
Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C
1/20/2016 5:04:00 PM |
Browse: 1440 |
Download: 2437
20
Ribavirin: Past, present and future
1/15/2016 9:49:00 AM |
Browse: 1631 |
Download: 2309
21
Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management
1/15/2016 9:49:00 AM |
Browse: 1609 |
Download: 2054
22
Hepatitis C genotype 4: The past, present, and future
12/4/2015 3:24:00 PM |
Browse: 2356 |
Download: 3115
23
Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients
12/2/2015 12:20:00 PM |
Browse: 2091 |
Download: 2406
24
Hepatitis C in hemodialysis patients
12/2/2015 12:01:00 PM |
Browse: 1678 |
Download: 2077
25
Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development
11/27/2015 5:17:00 PM |
Browse: 1689 |
Download: 3227
26
Hepatitis E virus infection: Epidemiology and treatment implications
11/12/2015 5:09:00 PM |
Browse: 1515 |
Download: 2766
27
Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance
11/9/2015 6:35:00 PM |
Browse: 1632 |
Download: 2240
28
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens
6/29/2015 4:40:00 PM |
Browse: 1590 |
Download: 3071
29
Hepatitis C: New challenges in liver transplantation
5/20/2015 5:01:00 PM |
Browse: 1478 |
Download: 2906
30
Natural interferon-beta treatment for patients with chronic hepatitis C in Japan
5/19/2015 5:28:00 PM |
Browse: 1627 |
Download: 2314
31
Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study
5/18/2015 5:02:00 PM |
Browse: 1727 |
Download: 2151
32
Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection
5/18/2015 5:02:00 PM |
Browse: 1407 |
Download: 2394
33
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control
3/30/2015 5:46:00 PM |
Browse: 1737 |
Download: 2776
34
Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6
3/13/2015 3:29:00 PM |
Browse: 1678 |
Download: 2324
35
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings
2/11/2015 5:56:00 PM |
Browse: 1835 |
Download: 2561
36
Retreatment with peginterferon and ribavirin in chronic hepatitis C
2/11/2015 5:56:00 PM |
Browse: 1515 |
Download: 1968
37
Study of pruritus in chronic hepatitis C patients
12/20/2014 9:24:00 PM |
Browse: 1454 |
Download: 2375
38
Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection
12/5/2014 11:43:00 AM |
Browse: 1553 |
Download: 2258
39
New treatments for chronic hepatitis C: an overview for paediatricians
12/5/2014 11:43:00 AM |
Browse: 1780 |
Download: 2645
40
Telaprevir/boceprevir era: From bench to bed and back
9/16/2014 8:07:00 PM |
Browse: 1760 |
Download: 2142
41
Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients
9/16/2014 4:56:00 PM |
Browse: 1498 |
Download: 1374
42
Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C
9/16/2014 3:23:00 PM |
Browse: 1395 |
Download: 1228
43
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation
9/15/2014 8:53:00 PM |
Browse: 1558 |
Download: 1711
44
Hepatitis C, stigma and cure
9/12/2014 8:41:00 PM |
Browse: 1727 |
Download: 1654
45
Hepatitis C genotype 6: A concise review and response-guided therapy proposal
9/10/2014 4:40:00 PM |
Browse: 1521 |
Download: 1644
46
Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy
9/5/2014 2:19:00 PM |
Browse: 1352 |
Download: 1644
47
Challenges in managing hepatitis C virus infection in cancer patients
9/1/2014 2:51:00 PM |
Browse: 1354 |
Download: 1356
48
Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection
9/1/2014 2:51:00 PM |
Browse: 1528 |
Download: 1907
49
Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
8/28/2014 5:50:00 PM |
Browse: 1793 |
Download: 1819
50
Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
8/26/2014 3:10:00 PM |
Browse: 1516 |
Download: 2198
Page 1 of 2 ( 52 items )
<<
1
2
>>
Write to the Help Desk
All content on this site:
Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.